A. Colorectal Cancer research hub

A CR-UK Phase I Trial of LY3143921

This study is testing a new drug, LY3143921 hydrate, for advanced solid cancers. It aims to find a safe dose, understand side effects, and see how well it works. This drug targets a specific process in cancer cells to stop their growth.